AU2021104015A4 - Composition of nadh for relieving alcohol and protecting liver and use thereof - Google Patents

Composition of nadh for relieving alcohol and protecting liver and use thereof Download PDF

Info

Publication number
AU2021104015A4
AU2021104015A4 AU2021104015A AU2021104015A AU2021104015A4 AU 2021104015 A4 AU2021104015 A4 AU 2021104015A4 AU 2021104015 A AU2021104015 A AU 2021104015A AU 2021104015 A AU2021104015 A AU 2021104015A AU 2021104015 A4 AU2021104015 A4 AU 2021104015A4
Authority
AU
Australia
Prior art keywords
nadh
composition
liver
alcohol
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2021104015A
Inventor
Jiansheng Chen
Zhigang DUAN
Yaying Hou
Bo Zhang
Tong Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoboomlife Bio Technology Shenzhen Co Ltd
Original Assignee
Hoboomlife Bio Technology Shenzhen Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoboomlife Bio Technology Shenzhen Co Ltd filed Critical Hoboomlife Bio Technology Shenzhen Co Ltd
Priority to AU2021104015A priority Critical patent/AU2021104015A4/en
Application granted granted Critical
Publication of AU2021104015A4 publication Critical patent/AU2021104015A4/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7084Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • A61K9/4825Proteins, e.g. gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10Preparation or pretreatment of starting material
    • A61K2236/17Preparation or pretreatment of starting material involving drying, e.g. sun-drying or wilting
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present application relates to the field of research and development of nutritional 5 supplements, in particular relates to a composition of NADH for relieving alcohol and protecting liver and an application of the composition of NADH. The present application provides a composition of NADH for relieving alcohol and protecting liver ,and the main components comprise NADH, curcumin and silybum marianum. NADH can increase the level of NAD+ in the body and accelerate the catabolism of acetaldehyde. Curcumin can stimulate the liver to 0 produce more acetaldehyde deoxygenase, so as to improve the metabolic ability of the liver to alcohol. Silybum marianum contains a large amount of silymarin and flavonoids, which can protect the enzyme system of liver cells and prevent liver damage. By the synergistic effect of the three components, the present application provides a comprehensive anti-alcohol and liver protection composition for multiple links, which can effectively anti-alcohol and protect the liver 5 with remarkable effects.

Description

COMPOSITION OF NADH FOR RELIEVING ALCOHOL AND PROTECTING LIVER AND USE THEREOF FIELD OF THE APPLICATION
The present application relates to the field of research and development of nutritional supplements, and in particular relates to a composition of NADH for relieving alcohol and protecting liver and an application of the composition of NADH.
BACKGROUND OF THE APPLICATION
Traditional Chinese medicine theory believes that a small amount of alcohol can prevent diseases and be beneficial for health, but long-term, excessive drinking or drinking of poor-quality wine can damage the human body and cause a variety of complex diseases. The toxicity of alcohol can affect the organs of the whole body, especially the most harmful for the liver. How to reduce and eliminate the toxic and side effects of alcohol, prevent and treat alcohol-related diseases is a hot issue in today's society.
At present, the relieve alcohol products on the market mainly speed up the metabolism of alcohol by increasing alcohol dehydrogenase, or use drugs to improve liver and kidney function to relieve the damage of the liver caused by alcohol and repair damaged liver cells. Some products even add diuretics, agonists and other components, these substances are drugs that have side effects and may increase the potential harm to the body while relieving alcohol and resisting drunkenness.
SUMMARY OF THE APPLICATION
The purposes of the present application are to overcome the above-mentioned disadvantages of the prior art, and provide a composition of NADH for relieving alcohol and protecting liver and an application of the composition of NADH.
In order to solve the above technical problems, the present application provides the following technical solutions.
A composition of NADH for relieving alcohol and protecting liver, the composition comprises NADH, curcumin and silybum marianum.
Further, the composition of NADH comprises 5 to 80 parts by weight of NADH, 5 to 15 parts by weight of curcumin, and 8 to 40 parts by weight of silybum marianum.
Preferably, the composition of NADH comprises 10 to 30 parts by weight of NADH, 8 to 12 parts by weight of curcumin, and 10 to 30 parts by weight of silybum marianum.
Further, the composition of NADH further comprises one or more excipients selected from the group consisting of mannitol, erythritol, microcrystalline cellulose, extract of artichoke, extract of pueraria, extract of hovenia dulcis, extract of schisandra chinensis, extract of oyster, taurine, calcium pantothenate, L-cysteine, vitamin B6, vitamin C, zinc gluconate, sodium bicarbonate, sodium vitamin C, xylitol, sorbitan fatty acid ester, magnesium stearate, croscarmellose sodium, pregelatinized starch, silicon dioxide, lactose, stomach soluble coating agent and enteric coating agent.
An application of any one of the above-mentioned compositions of NADH in anti-alcohol and liver protection.
Further, the composition can be made into any one of tablets, capsules, soft capsules, granules, pills, powders, films, drop pills, solid dispersions, pellets and liposomes.
The beneficial effects of the present application are as follows.
(1) NADH is used for relieving alcohol for the first time. In order to make acetaldehyde rapidly catabolize and metabolize, one of the important processes is to increase the level of NAD+ in the body. By supplementing NADH, it can increase the level of NAD+, so that reducing harmful free radicals, accelerating alcohol metabolism, relieving alcohol and protecting liver.
(2) Curcumin is a kind of natural liver antidote. After taking it, it will stimulate the liver to produce more acetaldehyde deoxygenase to accelerate the decomposition of acetaldehyde and improve the metabolic ability of the liver to alcohol. The silybum marianum contains a large amount of silymarin and flavonoids, which can stabilize the liver cell membrane, protect the enzyme system of the liver cell, remove the active oxygen free radicals of the liver cell, thereby improve the alexipharmic ability of liver and prevent liver damage.
(3) The synergistic effect of each substance of the components of the present application has significant effects on improving the oxygen supply of cells, accelerating the ability of the liver to relieve alcohol, and alleviating the symptoms after drinking.
DETAILED DESCRIPTION OF THE EMBODIMENTS
For more clearly understand the purposes, technical solutions, and advantages of the present application by those ordinary skilled people in the art, the present application will be further illustrated by the following embodiments.
Example 1
Firstly, NADH was passed through a 60 to 80 mesh sieve. The curcumin and silybum marianum were dried, and then passed through a 60-80 mesh sieve, respectively. The sieved NADH, curcumin and silybum marianum were put into a blender at 10:10:40 parts by weight for mixing, then stirred at 20r/min for 20 min, and a first product was obtained.
Appropriate amounts of mannitol, microcrystalline cellulose, sodium bicarbonate, sodium vitamin C, and magnesium stearate were passed through a 60-80 mesh sieve, respectively, and then put into the blender to mix with the first product. The resulting mixture was stirred at 20r/min for 40 minutes, after that the mixture was tableted compressing and composition 1 was obtained.
Example 2
The dried NADH, curcumin and silybum marianum were smashed respectively, and then passed through a 80-120 mesh sieve. The sieved NADH, curcumin and silybum marianum were mixed at 45:5:10 by weight, and a first product was obtained.
An appropriate amount of beeswax was took and heated to melt, then added the first product and stirred evenly, then added an appropriate amount of linseed oil at 6080°C. The resulting mixture was stirred evenly and kept at 40°C, the second product was obtained.
The gelatin, glycerin and water were added into a sol pot, heated to 80~100°C until melt, then the titanium dioxide, food coloring, and so on were added, and mixed evenly to make soft
capsules, and the soft capsules were kept at 60±2°C.
The second product and the soft capsules were pelleted, and a composition 2 was obtained.
Experimental examples
Alcoholic liver disease is a progressive development of disease. For excessive drinkers, ethanol will undergo a large amount of dehydrogenation under the catalysis of alcohol dehydrogenase in the body, and oxidize to acetaldehyde, which makes the tricarboxylic acid cycle disorder and fatty acid oxidation weaken, so that affects fat metabolism. Ethanol can cause Alpha-phosphate glycerol increases and promote the synthesis of triglycerides, thereby causing fat to be deposited in liver cells.
A total of forty Kunming mice weighing 20-25g SPF grade, half male and half female, were purchased from Zhejiang Animal Experimental Center. Anhydrous ethanol was purchased from Sinopharm Chemical Reagent Co., Ltd., alanine aminotransferase (ALT) and aspartate aminotransferase (AST) kits were purchased from Changchun Huili Technology Co., Ltd., and triglyceride (TG) detection kits were purchased from Nanjing Jiancheng Institute of Biological Engineering.
Forty mice were randomly divided into a normal group, a model group, an example composition 1 group, and an example composition 2 group, and a total of 4 groups, each with 10 mice. The normal group and the model group were fed normally, and the example groups were fed with the composition of corresponding example at 100mg/kg daily. After continuous feeding for 5 days, the mice in the model group and the example groups were given intragastric treatment with 50% ethanol diluted with distilled water at 16 mL/kg body weight, and the mice in the normal group was given the same dose of normal saline. After 24 hours of intragastric treatment, chloral hydrate with 10% mass fraction was injected intraperitoneally at 30mg/kg body weight, the blood vessels were exposed through a median abdominal incision, and the blood was collected from the abdominal aorta to separate the serum, and liver perfusion was performed to remove the liver tissue. AST, ALT and TG were detected according to the test method of the kit instructions, and the results were shown in the table below. Compared with the model group and the normal group, liver function damage effects were significantly reduced in the mice fed with the composition of the examples.
Index TG(mmol/L) AST(U/L) ALT(U/L)
Example composition 1 0.99 52.54 109.87
Example composition 2 1.21 56.78 115.98
Model group 1.68 75.85 139.48
Normal group 0.84 50.63 103.03
The above are only the preferred embodiments of the present application, and the protection scope of the present application is not limited to the above-mentioned embodiments. All technical solutions under the idea of the present application belong to the protection scope of the present application. It should be pointed out that for those ordinary skilled people in the art, several improvements and modifications without departing from the principle of the present application should also be regarded as the protection scope of the present application.

Claims (6)

1. A composition of NADH for relieving alcohol and protecting liver, wherein the composition comprises NADH, curcumin and silybum marianum.
2. The composition of NADH according to claim 1, wherein the composition comprises 5 to 80 parts by weight of NADH, 5 to 15 parts by weight of curcumin, and 8 to 40 parts by weight of silybum marianum.
3. The composition of NADH according to claim 2, wherein the composition comprises 10 to 30 parts by weight of NADH, 8 to 12 parts by weight of curcumin, and 10 to 30 parts by weight of silybum marianum.
4. The composition of NADH according to any one of claims 1 to 3, wherein the composition further comprises one or more excipients selected from the group consisting of mannitol, erythritol, microcrystalline cellulose, extract of artichoke, extract of pueraria, extract of hovenia dulcis, extract of schisandra chinensis, extract of oyster, taurine, calcium pantothenate, L-cysteine, vitamin B6, vitamin C, zinc gluconate, sodium bicarbonate, sodium vitamin C, xylitol, sorbitan fatty acid ester, magnesium stearate, croscarmellose sodium, pregelatinized starch, silicon dioxide, lactose, stomach soluble coating agent and enteric coating agent.
5. An application of the composition of NADH according to any one of claims 1 to 3 in anti alcohol and liver protection.
6. The application according to claim 5, wherein the composition can be made into any of tablets, capsules, soft capsules, granules, pills, powders, films, drop pills, solid dispersions, pellets and liposomes.
AU2021104015A 2021-07-09 2021-07-09 Composition of nadh for relieving alcohol and protecting liver and use thereof Active AU2021104015A4 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2021104015A AU2021104015A4 (en) 2021-07-09 2021-07-09 Composition of nadh for relieving alcohol and protecting liver and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2021104015A AU2021104015A4 (en) 2021-07-09 2021-07-09 Composition of nadh for relieving alcohol and protecting liver and use thereof

Publications (1)

Publication Number Publication Date
AU2021104015A4 true AU2021104015A4 (en) 2021-09-09

Family

ID=77563728

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2021104015A Active AU2021104015A4 (en) 2021-07-09 2021-07-09 Composition of nadh for relieving alcohol and protecting liver and use thereof

Country Status (1)

Country Link
AU (1) AU2021104015A4 (en)

Similar Documents

Publication Publication Date Title
CN104740412B (en) A kind of Medicament for Alcoholism composition and preparation method thereof
CN101836725B (en) Application of red rice residue product in preparing health-care food for lowering blood fat
CN102697035A (en) Cordyceps anti-aging pellet
WO2010081259A1 (en) A composition comprising extraction of fucoxanthin
WO2020052074A1 (en) Extract for improving liver detoxification, dispelling alcohol and protecting liver, and preparation method therefor
CN103191214B (en) Preparation for relieving or neutralizing effect of alcohol and protecting liver
CN109602756A (en) A kind of sobering-up composition and the preparation method and application thereof
CN102526346B (en) Health-care pharmaceutical formulation with immunity-enhancing and senility-delaying functions
AU2021104015A4 (en) Composition of nadh for relieving alcohol and protecting liver and use thereof
CN101244084B (en) Sobering-up agent of pearl oyster and preparation thereof
CN103977390B (en) A kind of preparation method and its usage of ginger onion medicated wine composition
CN109453267A (en) Sobering-up composition and the preparation method and application thereof
WO2019100843A1 (en) Enteromorpha prolifera polysaccharide composite blood lipid-lowering health care product and preparation method therefor
CN106822338A (en) Compound of reducing blood sugar and blood fat, prevention and/or treatment diabetes and its complication and application thereof
CN103054906A (en) Propolis ethanol extract for alleviating hangover and preparation method thereof, and application of propolis ethanol extract in producing buccal tablets
CN1861099B (en) Snake oil soft capsule
CN117771282B (en) Application of ganoderma lucidum in preparation of anti-alcohol product or product for preventing and treating liver and heart injury caused by drinking
KR20190111726A (en) A composition for preventing or treating obesity comprising natural mixture extracts
CN102657333B (en) Blood pressure reducing and heart protecting composite nutrient and preparation method thereof
CN109985206A (en) For preventing and treating the composition of alcoholic liver injury
CN104069173B (en) Treat pharmaceutical composition of liver diseases and preparation method thereof
CN117981877B (en) Anti-alcohol liver-protecting composition and application thereof
CN108244638A (en) Kalimeris fermentate and its preparation method and application
CN108720013A (en) The formula and processing technology of the health food of one group of Soboring-up liver-protecting being made of fructose and tea extract
TWI440465B (en) Herbal extract mixture for reducing blood lipid and a combination thereof

Legal Events

Date Code Title Description
FGI Letters patent sealed or granted (innovation patent)